Switch to:
Compare with: Competitors | Same P/E | Same P/S | Same Market Cap

Stocks under comparison: (Change symbols to compare, comma separated)

CompanyPfizer Inc (PFE) GlaxoSmithKline PLC (GSK) Johnson & Johnson (JNJ) Roche Holding AG (RHHBY) Novartis AG (NVS) Abbott Laboratories (ABT) 
Number of Guru Holders14 19  
Combined Weightings (%)12.39 6.24 53.95  8.63 4.47 
Number of Guru Buys:Sells (3 months)6 : 10 6 : 2 6 : 11 0 : 1 2 : 3 5 : 2 
Number of Guru Buys:Sells (6 months)12 : 12 10 : 5 16 : 17 1 : 1 5 : 4 10 : 5 
Number of Guru Buys:Sells (12 months)16 : 18 13 : 7 20 : 24 2 : 1 7 : 5 14 : 10 
Number of Insider Buys (3 months)
IndustryDrug Manufacturers - MajorDrug Manufacturers - MajorDrug Manufacturers - MajorDrug Manufacturers - MajorDrug Manufacturers - MajorDrug Manufacturers - Major
Price$29.39 $49.10 $103.73 $36.51 $89.84 $42.24 
Market Value (mil)$186,358 $117,938 $292,548 $248,091 $217,970 $63,516 
Revenue (mil)$51,584 $44,175 $71,312 $51,978 $58,831 $21,848 
P/E(ttm)18.40 15.20 19.20 20.20 23.30 27.70 
P/S3.80 2.90 4.10 4.80 3.90 
P/B2.50 11.60 3.80 10.60 3.20 2.70 
EV/EBIT14.15 13.39 13.88 14.30 19.39 24.60 
EV/Sales3.79 3.38 3.78 5.01 3.90 2.93 
Yield (%)3.50 5.40 2.60 1.90 
Payout0.63 0.81 0.50 0.63 0.73 0.52 
ROA (%)12.78 12.92 10.42 17.96 7.27 
ROE (%)28.83 77.69 18.68 52.56 12.34 10.23 
Operating Margin (%)30.47 26.52 25.77 35.01 18.54 12.03 
Net Margin (%)42.65 20.51 19.40 23.86 15.60 11.79 
Debt to Equity (%)49 289 22 77 29 31 
10-Year Rvn. Growth (%)2.10 5.40 4.90 3.40 5.20 5.30 
10-Year Earning Growth (%)0.20 1.50 7.70 1.70 -5.50 
5-Year Rvn. Growth (%)0.40 -1 3.10 -1.40 0.90 -5.90 
5-Year Earning Growth (%)7.70 11.50 -0.40 8.30 -3.80 -32.40 
1-Year Rvn. Growth (%)3.80 -6.90 4.20 -0.10 -1.80 -28.70 
1-Year Earning Growth (%)8.90 21.30 20.20 -3.90 0.60 167.30 

Add this list into my watchlist/portfolio:

1. Add or remove tickers (Comma separated)

2. Select destination portfolio


You need to log in to proceed

3. Click the button to finish



Add Notes, Comments or Ask Questions

User Comments

SEENSCO
ReplySEENSCO - 2 months ago
PFE is trading at the low end of our short-term valuation range ($29-$36) and significantly below our Fair Value estimate of $42.41.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK